Barclays’s NEVRO CORP. NVRO Stock Holding History

Barclays’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-124,400	Closed	-$10.1M	–	5737
2021 Q4	$10.1M	Buy	124,400 +103,500	+495%	+$10.4M	﹤0.01%	1264
2021 Q3	$2.43M	Buy	+20,900	New	+$2.74M	﹤0.01%	2179
2019 Q1	–	Sell	-75,000	Closed	-$2.92M	–	7391
2018 Q4	$2.92M	Buy	75,000 +58,000	+341%	+$2.58M	﹤0.01%	2030
2018 Q3	$969K	Sell	17,000 -8,000	-32%	-$500K	﹤0.01%	3654
2018 Q2	$2M	Buy	+25,000	New	+$2.07M	﹤0.01%	2587
2017 Q4	–	Sell	-2,800	Closed	-$254K	–	7167
2017 Q3	$254K	Buy	+2,800	New	+$240K	﹤0.01%	4221
2017 Q2	–	Sell	-2,700	Closed	-$253K	–	6993
2017 Q1	$253K	Buy	+2,700	New	+$245K	﹤0.01%	4081
2015 Q3	–	Sell	-85,000	Closed	-$4.5M	–	7101
2015 Q2	$4.5M	Buy	+85,000	New	+$4.33M	0.01%	1572

Other funds holding NVRO

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Barclays's NVRO Position: Q2 2025 in Review

Barclays sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 51,151 shares — an estimated $299K sold.

Barclays first reported a position in NVRO in Q4 2014 and held it in 42 quarters. The position peaked at $10.4M in Q4 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

Barclays reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
Barclays sold 51,151 NEVRO CORP. shares in Q2 2025, an estimated $299K.
Barclays first reported a position in NEVRO CORP. in Q4 2014 and held it in 42 quarters.
Barclays's NEVRO CORP. position peaked at $10.4M in Q4 2021.
1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.